Cheng Zu

4PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 18, 2026
Regulation of immune checkpoint molecules in cancer immune evasion and therapy.

|Apr 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.

Yongxian Hu, Mingming Zhang, Tingting Yang

|Mar 31, 2023
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy.

Shan Fu, Qiqi Zhang, Ruirui Jing

|Feb 24, 2022
Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

Cheng Zu, Yufeng Xu, Yiyun Wang

Pageof 1

Frequent Collaborators

2 joint publications

Yongxian Hu

1 joint publications

He Huang

1 joint publications

Yanling Xiao

1 joint publications

Michael Platten